InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Auster Martin. Officer active across 1 company, notably Ventyx Biosciences, Inc.. Aggregated, 10 filings have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €3.2m. Activity tracked since 2 December 2022. The latest transaction was disclosed on 2 April 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Auster Martin is Chief Financial Officer at Ventyx Biosciences, Inc. He has 10 filings in total. Across the 10 recent filings we hold, they cover the period from 2022-12-06 to 2024-04-03, with 0 in buys and 3,248,645 in sells, and the most common transaction nature is Exercise of options.